Form D · Pharmaceuticals
NOXX Therapeutics, Inc.
Boca Raton, FL · CIK 0001996801
Offering snapshot reported Mar 31, 2026 · SEC filing
- Reported sold
- $1M Offering amount: $1M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 23, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 31, 2026 | Initial | $1,000,000 | No comparison | 11 | SEC filing |
| Oct 11, 2023 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-578524
Source: Form D, filed Mar 31, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dave Adams | Director |
| Robert Finizio | Director |
| Kurt Gehlsen | Director, Executive |
| Brian P Mooney | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3000 Military Trail #103
Boca Raton, FL, 33431
Phone: 520-904-8396
Boca Raton, FL, 33431
Phone: 520-904-8396